Overview

Posaconazole vs Itraconazole in Preventing IFD Post-HSCT

Status:
Unknown status
Trial end date:
2020-04-01
Target enrollment:
Participant gender:
Summary
Invasive Fungal Disease (IFD) after haematopoietic stem cell transplantation (HSCT) remain a clinical challenge.The studay aims to compare the efficacy and safety of posaconazole oral suspension vs itraconazole oral solution in preventing IFD post-HSCT.
Phase:
Phase 2/Phase 3
Details
Lead Sponsor:
Fujian Medical University
Treatments:
Antifungal Agents
Clotrimazole
Hydroxyitraconazole
Itraconazole
Miconazole
Posaconazole